Which Emerging Markets Are Vulnerable To Higher Oil Prices: Chart

Brent crude for December 2018 delivery closed at over $84 on Friday. Oil prices have soared in the past year and continue to power higher. Supply issues in Venezuela and Iran are also adding further pressure on oil prices. U.S. sanctions on Iran will take effect on November 5, 3018 which will have more impact on global prices.

Rising oil prices have a substantial impact on emerging markets with some countries affected more than others. Countries that are net importers will be impacted adversely while oil export countries stand to benefit from higher prices. For example, if oil prices reach $100 a barrel oil exporters will earn higher revenue for the same amount of oil produced and exported. According to Bloomberg, Saudi Arabia, Mexico and Russia are poised to benefit. Oil importing countries such as South Africa, South Korea, India and Thailand will be negatively impacted by rising oil prices.

Click to enlarge

Source: Bloomberg via We Could See $100 Oil Again Soon, But Not for the Reason You Think, U.S. Funds

Gold Returns in Various Currencies 2001 Thru 2017

Gold prices are down so far this year. However gold as an asset class has returned positive returns in various currencies from 2001 thru 2017.

The performance of gold in various currencies is shown in the table below:

Click to enlarge

Source: IGWTreport, Incrementum

The average annual performance of gold between 2001 and 2017 was 9.17%. During period gold has outperformed practically every other asset class in particular in every currency according to the above linked report.

Download:

The S&P Biotechnology Select Industry Index Returns: Chart

The S&P Biotechnology Select Industry Index is one of the major indices that tracks the biotech sector. The index is up just 8% YTD while the NYSE Arca Biotechnology Index has shot up over 23%.

Click to enlarge

Source: S&P Indices

Overall Biotech stocks have performed so far well this year. Investors interested in the sector can check out the options available on the NASDAQ market.

European Stocks Are Attractively Valued Now: Chart

European equities are attractive relative to their US peers based on cyclically-adjusted price-to-earnings ratio (CAPE) according to an article by Rory Bateman at Schroders. The following chart shows the comparison of valuations since 1982:

Click to enlarge

Source: Can European equities play catch-up in Q4?, Schroders

A short excerpt from the above article:

In summary, we are encouraged by the recent rotation in the market favouring more cyclical value stocks and moving away from expensive defensives.

The overall market valuation remains attractive with the cyclically-adjusted price-to-earnings ratio (CAPE) trading 20% below historical averages. The massive performance differential versus the US has recently begun to close and we expect this to continue.

Markets remain susceptible to volatile periods and we would suggest investors be opportunistic and take advantage of this volatility to buy assets that become mispriced.